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Introduction
Sensory relearning (SR), also known as sensory 
retraining, is a behavioural intervention that makes 
use of ‘learning-dependent’ cortical plasticity. Graded 
tactile stimuli are used in combination with attention 
and intermittent use of visual feedback to facilitate 
improved tactile discrimination in the hand or upper 
limb (Jerosch-Herold, 2011). There is moderate evi-
dence of its effectiveness in the treatment of func-
tional sensory deficits in the hand secondary to 
peripheral nerve injury (Miller et al., 2012) and stroke 
(Carey et al., 2011; Schabrun and Hillier, 2009), as 
well as in the face following injury and surgery to the 
trigeminal nerve (Phillips et al., 2011).
Carpal tunnel syndrome is the most common 
entrapment neuropathy of the upper limb, charac-
terized by signs and symptoms including pain, tin-
gling, weakness and numbness in the distribution of 
the median nerve of the hand. The compression of 
the nerve leads to altered and decreased sensory 
input or, in severe cases, even a complete absence 
of sensation in the median nerve innervated terri-
tory of the hand (Middleton and Anakwe, 2014). This, 
in turn, causes maladaptive cortical changes in the 
somatotopy as demonstrated in functional magnetic 
resonance image (fMRI) studies (Maeda et al., 2013, 
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2014; Napadow et al., 2006). Although surgery can 
effectively alleviate symptoms of pain, tingling and 
numbness, those with severe and longer duration of 
symptoms are often left with chronic sensory dis-
turbance (Middleton and Anakwe, 2014).
SR is not routinely offered to patients who have 
chronic sensory deficits after carpal tunnel decom-
pression (Jerosch-Herold, 2011). To the best of our 
knowledge, only one pilot study has investigated the 
feasibility and acceptability of this intervention in car-
pal tunnel syndrome (Jerosch-Herold et al., 2012).
The objective of this definitive trial was to investi-
gate whether a SR intervention taught as an unsu-
pervised 6-week home therapy programme can 
improve tactile discrimination and self-reported 
hand function in patients with chronic sensory defi-
cits after carpal tunnel decompression.
Methods
Study design and setting
This pragmatic, assessor-blinded, randomized con-
trolled trial was conducted with the Norwich Clinical 
Trials Unit at the University of East Anglia. The term 
‘pragmatic’ is used here in the context of a pragmatic 
trial (does an intervention work in those who are 
offered it?) as opposed to an ‘explanatory’ trial (does 
an intervention work under ideal conditions?) (Roland 
and Torgerson, 1998). Identification of potentially eli-
gible patients took place in a large secondary care 
teaching hospital by searching the surgery records of 
the departments of Plastic & Reconstructive Surgery 
and Orthopaedics for patients who had carpal tunnel 
decompression at least 12 months ago or longer. The 
same method was also used in two primary care sites 
in Norfolk where carpal tunnel decompression is 
performed.
The screening, clinical assessment and subse-
quent randomization of eligible patients was con-
ducted in four consecutive waves between February 
2014 and February 2015. The National Research 
Ethics Service (REC reference 13/EE/0149) and local 
Research & Development departments at participat-
ing sites gave approval prior to study commence-
ment. All patients gave written informed consent.
Screening and selection
Screening for eligible patients was a two-stage pro-
cess. First, all patients over 18 years of age who had 
undergone decompression surgery at least 12 months 
previously were sent an invitation to participate, 
including a participant information sheet and screen-
ing questionnaire. The screening questionnaire asked 
patients to rate any numbness (loss of feeling) in 
their hand (none = 1, mild = 2, moderate = 3, severe 
= 4 and very severe = 5) and any difficulty with grasp-
ing and use of small objects (no difficulty = 1, mild = 
2, moderate = 3, severe = 4 and very severe difficulty 
= 5). Patients were asked which hand their responses 
referred to (left, right, both) and to indicate any other 
co-morbidities affecting their hand(s). Personal con-
tact details and basic demographic information were 
requested to enable contact by the trial research 
staff.
Second, those indicating at least mild numbness 
and difficulty (score ⩾2 in each) in a previously oper-
ated hand were invited to attend the Norwich Clinical 
Trials Unit for a clinical assessment using validated 
sensory tests. Patients with sensory impairment sec-
ondary to other known aetiologies, such as stroke, 
were excluded.
Sensory impairment of the affected hand was 
assessed using standardized tests of sensibility, 
which are responsive in patients undergoing carpal 
tunnel surgery (Jerosch-Herold et al., 2011). Where 
patients had undergone bilateral decompression, the 
worst hand was assessed. Where both hands had 
similar levels of sensory impairment, the dominant 
hand was chosen. The tests assessed three aspects 
of sensory function: touch threshold (Weinstein 
Enhanced Sensory Test (WEST)), area localization 
(locognosia test) (Jerosch-Herold et al., 2006) and 
tactile gnosis (Shape-Texture Identification (STITM) 
test) (Rosen and Lundborg, 1998). All patients gave 
written informed consent prior to the baseline 
assessment. Patients with scores below normal on at 
least two out of the three clinical sensory tests were 
eligible to participate in the trial and issued with a 
further patient information sheet and consent form.
Randomization
Stratified blocked randomization with randomly per-
muted block lengths of two, four and six were used. 
The baseline tactile gnosis score (STI test) was used 
to stratify randomization by low (0–3 points) and high 
(4–6 points) STI score. The randomized sequence was 
generated by the data manager of the Norwich 
Clinical Trials Unit and held separately from the main 
study database.
Patients who were eligible for the trial following 
baseline assessment were seen by the Chief 
Investigator (CI) (first author) who answered any 
questions about the trial and obtained written con-
sent to participate before completing two further 
baseline measures: the Moberg Pick-up test (Moberg, 
1991) and three subscales of the Michigan Hand 
Questionnaire (MHQ) (overall hand function, activities 
of daily living (ADL) of affected hand and both hands, 
and work) (Chung et al., 1998).
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Blinding
Blinding of patients was not feasible in this trial. The 
allocation sequence was masked from the CI involved in 
randomizing patients to the trial (through online rand-
omization). Both research associates involved in base-
line and follow-up assessments were blind to group 
allocation. All randomized patients received verbal and 
written instructions not to divulge their group allocation 
to the assessor at both follow-up assessments.
Intervention – SR
The SR programme was developed for the trial, based 
largely on a programme used in a previous pilot trial 
(Jerosch-Herold et al., 2012), and was designed to be 
practised daily at home. Using the principles of 
learning-dependent cortical plasticity, the SR pro-
gramme proposes short intensive periods of tactile 
stimulation with and without vision, combined with 
cognitive learning techniques, to improve sensibility 
and function of the hand.
A standardized set of SR materials, as well as a 
booklet with written instructions and colour photo-
graphs, were given to patients. The CI explained and 
demonstrated the three SR exercises to patients 
emphasizing that these needed to be practised in a 
quiet environment for short periods (5–10 min) at least 
three times a day over 6 weeks. Patients were advised 
that they needed to modify the training materials to 
ensure that the exercises remained challenging, for 
example by incorporating smaller, more complex 
objects or relying less on vision and more on touch 
alone. It was emphasized that vision should be used 
only intermittently as feedback when identification by 
touch alone could not be accomplished. The first exer-
cise used a 30 mm wooden cube with four different 
grades of sandpaper to be identified in order of smooth-
est to roughest and a 20 mm playing dice with raised 
dots from one to six. The playing dice was designed to 
be carried in a trouser or coat pocket to facilitate fre-
quent daily practice. For the second exercise, an opaque 
cloth bag containing 14 small everyday items such as 
coins, buttons and screws was used. Patients had to 
identify each object by touch and without vision while 
attending to the feel of shape, weight, texture and form. 
For the third exercise, patients were asked to choose 
usual daily activities involving fine dextrous finger 
movement in which they needed to attend to the feeling 
of the shape, weight or texture of the items they were 
touching and using visual feedback only intermittently.
Control group
Patients in the control group were instructed to use 
their hands as they had before. At the end of their 
trial participation they were offered written instruc-
tions on SR, including a description of materials that 
can be found around the house (e.g. assorted nuts, 
screws, buttons, textured fabrics) and how to prac-
tise the SR programme.
Trial outcomes
All patients were assessed prior to randomization 
(baseline), at 6 weeks (end of treatment) and 12 weeks 
(end of follow-up). Each assessment comprised, in 
order of administration: (i) touch threshold (WEST) 
test; (ii) locognosia test; (iii) tactile gnosis (STI) test; 
(iv) Moberg Pick-up test; and (v) three sub-scales of 
the standardized MHQ. The methods of administra-
tion and scoring for the WEST, locognosia and STI 
tests have been described previously (Jerosch-Herold 
et al., 2011). Patient-perceived ability to use the hand 
in everyday activities and work was captured by three 
subscales of the validated MHQ.
The primary outcome was the tactile gnosis score 
assessed by the STI at 6 weeks. Secondary outcomes 
were the STI score at 12 weeks, touch threshold, 
locognosia test and Moberg Pick-up test and patient-
reported hand function (MHQ).
Data on adherence to the home SR programme 
were collected through a patient completed daily 
diary in which patients were asked each day to indi-
cate which exercises were completed, how often 
and for how long. The diary had 42 days (6 weeks) of 
rows to complete. At the end of the 6 weeks patients 
were asked to indicate if they continued with the 
exercises and, if so, why. They were also asked to 
comment on what they liked and disliked about the 
SR programme.
Sample size
The sample size calculation was based on data from 
a previous pilot trial (Jerosch-Herold et al., 2012), 
which observed a pooled standard deviation for the 
STI of 1.605. Using a 1.09 point change observed in 
STI score over 4 months in a group of 63 patients 
undergoing surgery and who considered themselves 
improved on a global rating scale (Jerosch-Herold 
et al., 2011) as being clinically relevant, this provides 
an effect size of 0.68 (i.e. 1.09/1.605). Based upon this 
effect size (0.68), a power of 90% and 5% significance 
level, 47 patients per group would be required. 
Allowing for a 25% loss to follow-up a total of 126 
randomized patients was aimed for.
Statistical analysis
The data analysis was conducted sub-group blind 
(i.e. the trial statistician did not know which group 
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was the intervention and which the control). An 
intention-to-treat (ITT) approach was used for the 
primary efficacy analysis, analysing patients 
according to the group to which they were rand-
omized irrespective of whether or not they carried 
out the SR exercises. A t-test, with 95% confidence 
interval was initially used to test for a difference in 
mean STI scores between the two groups. A general 
linear model was then constructed with the STI 
baseline score, severity of reported numbness and 
difficulty grasping at baseline as covariates (i.e. 
adjusted for baseline prognostic variables pre-
specified in the statistical analysis plan), to esti-
mate an ‘adjusted’ between-group mean difference, 
with 95% confidence interval. A similar approach 
was used for secondary endpoints.
A secondary analysis utilized complier-averaged-
causal-effects (CACE) approach (Hewitt et al., 2006) 
to estimate the effect size in those deemed to be 
adherent to SR. Adherence data in the intervention 
group was based on 38 diaries that were returned. 
‘Compliers’ (i.e. those adherent) were defined by clin-
ical expert members of the Trial Steering Committee 
for the Statistical Analysis Plan, with a patient 
deemed to be adherent if SR exercises were under-
taken at least once a day, for at least 5 days out of 7 
consecutive in a week and over at least three con-
secutive weeks. For a sensitivity analysis the thresh-
old was raised to a 6-week duration, with the same 
day and week frequency.
Data management
A trial specific Microsoft SQL (structured query lan-
guage) database was set up by the data manager at 
the Norwich Clinical Trials Unit, held on a secure 
server and accessed through password by the CI and 
two research associates. All data entry from paper 
clinical record forms was doubled-checked by a 
member of the research team prior to data lock.
Results
Trial participants
Between February 2014 and February 2015, 1629 
patients were mailed an invitation and screening 
questionnaire. Figure 1 shows the number of patients 
who met eligibility at the screening and clinical 
assessment stage and the flow of randomized 
patients through the trial, in accordance with the 
CONSORT statement (Schulz et al., 2010).
A total of 120 patients who reported at least mild 
numbness and mild difficulty with grasping objects 
attended for clinical assessment of hand sensibil-
ity. Of these, 106 (88%) were found to have sensory 
impairment on at least two out of three tests. A 
total of 104 patients consented and were randomly 
assigned to the intervention (n = 52) or control 
group (n = 52). Baseline characteristics are sum-
marized in Table 1.
Ten patients withdrew, all from the intervention 
group (9.6%), and one patient was lost to follow-up in 
the control group. One patient in the intervention 
group missed the 6-week follow-up due to illness, 
but attended assessment at 12 weeks. Outcomes at 
12 weeks were, therefore, obtained for 93 partici-
pants (89.4%). Patients who withdrew or were lost to 
follow-up tended to have poorer sensory scores and 
greater functional disability. Reasons for withdrawal 
included deteriorating general health (n = 2), a per-
ceived lack of benefit to the trial (n = 2), frustration 
caused by perceived lack of improvement despite 
undertaking exercises (n = 2) and finding the exer-
cises boring or difficult to fit around work (n = 1). 
Patients who expressed a wish to withdraw were 
encouraged by research staff to discontinue the 
intervention only and to remain in the trial, however 
most declined as they felt they were no longer of ben-
efit to the trial.
Outcomes
One report of an adverse event was received, which 
may have been related to the intervention. The patient 
had ongoing pain in their hand and arm and reported 
that this seemed to be aggravated by the exercises. 
The patient was advised to discontinue the interven-
tion, the issue was discussed by the Trial Management 
Group and Steering Committee and no further action 
was taken. The patient completed the 6- and 12-week 
follow-up and was included in the analysis as per 
allocated arm (treatment group).
Unblinding of assessors occurred in 11 cases at 
the 6-week assessment and a further seven cases at 
the 12-week assessment. Most cases of unblinding 
were in the intervention group (nine at 6 weeks, five at 
12 weeks). In some instances this occurred when the 
research staff who were also assessors contacted 
patients to remind them of their appointment, but in 
most cases unblinding happened during the assess-
ment when patients noted that they had improved on 
objective tests and would attribute this to the ‘exer-
cises’. Assessors were asked to guess each patient’s 
group allocation after the final 12-week assessment. 
Excluding those who had unblinded the assessor, the 
assessors correctly guessed 54% to be in the inter-
vention group and 59% in the control group.
Tables 2 and 3 show the results of the ITT efficacy 
analysis at 6 and 12 weeks for the primary and sec-
ondary outcomes. There were no statistically signifi-
cant differences between the groups at 6 weeks on 
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Figure 1. CONSORT diagram.
Table 1. Baseline characteristics.
Intervention (n = 52) Control (n = 52)
Age mean (SD), years 71.8 (12.0) 70.8 (12.3)
Sex male/female 21 (40%)/31 (60%) 29 (56%)/23 (44%)
Dominant hand affected 29 (56%) 31 (60%)
Months since surgery, mean (range) 28.7 (11 to 106) 30.5 (13 to 73)
Self-reported numbness Mild
Moderate
Severe
Very severe
21 (40%)
22 (42%)
9 (17%)
0
24 (46%)
21 (40%)
7 (13%)
0
Self-reported difficulty grasping Mild
Moderate
Severe
Very severe
20 (38%)
19 (37%)
12 (23%)
1 (2%)
25 (48%)
17 (33%)
8 (15%)
2 (4%)
Previous injury or fracture 4 (8%) 4 (8%)
Past stroke 3 (6%) 3 (6%)
Other co-morbidity affecting the hand 18 (35%) 19 (37%)
Shape-Texture Identification (0–6) 3.6 (1.7) 3.4 (1.7)
Touch threshold (WEST) (0–4) 2.3 (0.65) 2.5 (0.63)
Locognosia (0–56) 42.7 (7.6) 42.6 (8.3)
Moberg test (seconds) 55.4 (38.3) 49.7 (35.9)
MHQ – overall function 55.7 (13.4) 55.2 (15.2)
MHQ – ADL affected hand 61.7 (22.0) 64.8 (23.5)
MHQ – ADL both hands 62.3 (21.0) 60.1 (22.7)
MHQ – work 64.2 (19.0) 60.6 (24.4)
ADL: activities of daily living; MHQ: Michigan Hand Questionnaire; SD: standard deviation; WEST: Weinstein Enhanced Sensory Test.
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the STI test (adjusted mean difference −0.47, 95% CI 
−1.09 to 0.14, p = 0.129) or at 12 weeks (adjusted mean 
difference −0.18, 95% CI −0.78 to 0.42, p = 0.549). 
Similarly differences between groups on secondary 
outcomes were not statistically significant with the 
exception of the patient-reported subscales of the 
MHQ. These included overall hand function (adjusted 
mean difference −6.61, 95% CI −11.0 to −2.2, p = 0.003), 
ADL affected hand (adjusted mean difference −6.36, 
95% CI −12.5 to −0.3, p = 0.040) and bilateral ADL 
(adjusted mean difference −6.04, 95% CI −11.6 to 
–0.5, p = 0.032). The significant difference in the MHQ 
was retained in two subscales by 12 weeks (overall 
hand function and bilateral ADL).
Adherence diaries were received from 38 of the 42 
patients who completed all follow-up. A total of 17 
patients (45%) indicated that they continued to do the 
SR after 6 weeks, mostly because they felt it was benefi-
cial and hoped to see further improvement. They also 
found it easy and painless to do. Several patients aban-
doned the exercises within only a few days, while one 
patient undertook the exercises much more frequently 
and for longer periods resulting in a right skewed distri-
bution, therefore medians and interquartile range (IQR) 
were used to summarize the data (Table 4).
For the secondary CACE analysis, defining ‘com-
pliance’ on 3-week adherence to exercise, 28 patients 
(74%) in the intervention group were deemed ‘com-
pliers’, i.e. they reported the minimum dose of treat-
ment. A sensitivity analysis using a 6-week adherence 
threshold was performed in which 22 (58%) were 
deemed ‘compliers’ (Table 5). The estimates of treat-
ment effect on the STI test at 6 weeks and 12 weeks 
are larger relative to the ITT analysis but are not sta-
tistically significant.
Discussion
In this pragmatic, randomized, controlled trial we 
found that a 6-week unsupervised home SR pro-
gramme was not clinically effective in improving objec-
tive measures of hand sensibility in the short-term. 
The size of effect on the primary outcome (STI) at 
6 weeks is estimated at around half a point, but with an 
upper confidence limit that includes the size deemed 
clinically important and was used in the sample size 
calculation (i.e. 1.09 units) (Jerosch-Herold, 2003). The 
intervention did have a statistically significant effect on 
patient-reported hand function (MHQ subscales for 
overall hand function and ADL), however this must be 
interpreted with caution. First, those patients who 
withdrew (19%) from the intervention group and were 
therefore not included in the 6 and 12 weeks analysis, 
had poorer sensory and functional scores at baseline. 
Therefore, the better score seen in the intervention 
group may simply be a bias from excluding those in the 
group with the worst scores. Second, the mean differ-
ence is below what might be considered clinically 
important (Shauver and Chung, 2009). Third, the MHQ 
was patient-reported and therefore not blinded, which 
may have created a bias in response.
The secondary CACE analysis found that consider-
ing those adherent with the recommended exercise 
frequency and duration did not have a significant 
effect on the primary outcome. The effect was 
increased relative to that estimated with the ITT 
Table 2. Efficacy analysis: ITT analysis at 6 weeks.
Control
(n = 51)
Intervention
(n = 41)
Unadjusted mean  
difference (95% CI)
Adjusted mean  
difference1 (95% CI)
STI Score 3.63 (1.79) 4.20 (1.85) −0.57 (−1.32 to 0.19)
p = 0.139
−0.47 (−1.09 to 0.143)
p = 0.129
Locognosia Score 44.8 (6.66) 44.9 (8.71) −0.09 (−3.28 to 3.09) 
p = 0.954
−0.27 (−2.16 to 1.62)
p = 0.774
LogMoberg Score 3.72 (0.54) 3.66 (0.59) 0.06 (−0.17 to 0.30)
p = 0.601
0.02 (−0.12 to 0.16)
p = 0.776
WEST Score 2.52 (0.70) 2.73 (0.73) −0.21 (−0.51 to 0.084)
p = 0.159
−0.07 (−0.32 to 0.18)
p = 0.555
MHQ – Overall Function 52.0 (16.4) 60.2 (13.3) −8.28 (−14.6 to −2.0)
p = 0.010
−6.61 (−11.0 to −2.2)
p = 0.003
MHQ – ADL affected hand 60.8 (24.7) 70.7 (24.8) −9.95 (−20.2 to 0.35)
p = 0.058
−6.36 (−12.5 to −0.3)
p = 0.040
MHQ – ADL both hands 63.8 (22.6) 70.4 (22.9) −6.60 (−16.1 to 2.9)
p = 0.170
−6.04 (−11.6 to −0.5)
p = 0.032
MHQ – work 62.4 (20.6) 69.4 (24.7) −7.04 (−16.4 to 2.3)
p = 0.140
−3.83 (−2.5 to 10.2)
p = 0.231
1Adjusted for age, baseline score, difficulty grasping and numbness at baseline. Significance below 5% in bold.  
ADL: activities of daily living; CI: confidence interval; MHQ: Michigan Hand Questionnaire; STI: Shape-Texture Identification; WEST: Weinstein 
Enhanced Sensory Test.
 at University of East Anglia on July 12, 2016jhs.sagepub.comDownloaded from 
Jerosch-Herold et al. 7
analysis, especially when using the stricter definition 
of adherence (6 weeks), but this is to be expected 
when using a CACE analysis. Moreover, the lower 
confidence limit is >2, a difference that would be 
deemed clinically important for the STI test. The 
advantage of using CACE analysis, compared with per 
protocol analysis, is that it maintains comparability of 
groups achieved through randomization, assuming 
that the probability of non-compliance with the inter-
vention would be the same in the control and inter-
vention group (Hewitt et al., 2006). Both approaches 
will result in an estimated treatment effect larger 
than that estimated from the ITT approach.
Previous indications that SR may be beneficial 
observed in a pilot study (Jerosch-Herold et al., 2012) 
were not substantiated in this definitive trial. This 
was despite the intervention and follow-up period in 
the present trial being longer (6 and 12 weeks com-
pared with the 4 and 8 weeks in the pilot trial) and 
improvements being made to the SR programme to 
facilitate adherence. The eligibility criteria in the pre-
sent trial specified that patients had to be at least 
12 months since surgery as opposed to 6 months in 
the pilot trial. The mean time since surgery was much 
longer in the present trial, which may account for a 
more chronic sensory impairment that could also be 
more resistant to treatment.
One possible reason for the lack of effect is that 
‘dose’ and duration of the intervention were too low for 
learning to take effect. SR requires short but frequent 
Table 3. Efficacy analysis: ITT analysis at 12 weeks.
Control
(n = 51)
Intervention
(n = 42)
Unadjusted mean difference
(95% CI)
Adjusted mean difference1
(95% CI)
STI Score 4.02 (1.59) 4.19 (1.78) −0.17 (−0.87 to 0.53)
p = 0.627
−0.18 (−0.78 to 0.42)
p = 0.549
Locognosia Score 46.4 (7.41) 46.5 (7.47) −0.14 (−3.22 to 2.94)
p = 0.930
−0.28 (−2.23 to 1.68)
p = 0.777
LogMoberg Score 3.62 (0.53) 3.46 (0.53) 0.16 (−0.06 to 0.38)
p = 0.621
0.11 (−0.02 to 0.25)
p = 0.084
WEST Score 2.73 (0.69) 2.87 (0.62) −0.14 (−0.42 to 0.13)
p = 0.297
−0.02 (−0.26 to 0.213)
p = 0.853
MHQ – Overall Function 55.3 (15.1) 63.3 (17.2) −8.04 (−14.7 to −1.4)
p = 0.019
−5.87 (−10.8 to −1.0)
p = 0.019
MHQ – ADL Affected 
Hand
63.0 (23.9) 73.1 (25.1) −10.1 (−20.2 to 0.0)
p = 0.051
−6.56 (−14.1 to 1.0)
p = 0.085
MHQ – ADL Both Hands 65.1 (22.4) 73.8 (23.0) −8.68 (−18.1 to 0.7)
p = 0.070
−7.24 (−13.3 to −1.2)
p = 0.019
MHQ - Work 67.0 (20.2) 75.1 (20.9) −8.16 (−16.6 to 0.3)
p = 0.059
−4.50 (−10.1 to 1.1)
p = 0.110
1Adjusted for age, baseline score, difficulty grasping and numbness at baseline. Significance below 5% highlighted in bold.
ADL: activities of daily living; CI: confidence interval; MHQ: Michigan Hand Questionnaire; STI: Shape-Texture Identification; WEST: Weinstein 
Enhanced Sensory Test.
Table 4. Summary statistics for 6 week adherence diary (n = 38).
Recommended 
minimum
Diary reported adherence
 Median Interquartile range Minimum–maximum
Number of sessions per day 3 2 1–2 0 to 5
Total number of sessions over 6 week period (42 days) 126 102 55–115 7 to 210
Average total time per day (minutes) 15 14 11.75–20 2 to 127
Total duration over 6 weeks (minutes) 630 598 410–842 42 to 5246
Table 5. Secondary CACE analysis.
STI at 6 weeks
Mean difference (95% CI)
STI at 12 weeks
Mean difference (95% CI)
Adherence threshold 3 weeks minimum −0.77 (−1.81 to 0.28) −0.23 (−1.18 to 0.72)
Adherence threshold 6 weeks minimum −0.97 (−2.28 to 0.35) −0.29 (−1.48 to 0.96)
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practice in tactile discrimination tasks. In this study 
patients were given an unsupervised home pro-
gramme. The exercises may not have been enacted as 
intended and there was no interaction with the study 
team between baseline and 6-week follow-up to check 
on progress and understanding. Such interaction may 
also have helped mitigate the attrition in the interven-
tion group. Second, we cannot rule out the possibility 
that patients in the control group may have changed 
the way they used their hands, or sought information 
about SR through the internet. The sensory tests may 
have resulted in patients attending more to tasks 
requiring touch perception and discrimination. Both 
groups showed a small improvement in sensory 
scores over time. This could also be due to a practice 
effect from repeated sensory testing.
Another plausible reason for the lack of observed 
effect may be that the intervention was too generic and 
that a ‘one size fits all’ approach does not work. SR was 
standardized, but some patients noted in their diaries 
that they found certain exercises, such as the object 
identification, too easy. We did emphasize the need for 
patients to self-monitor and replace the objects with 
ones that were smaller and increasingly complex. 
Some patient diaries indicated that they replaced 
objects and also began to transfer the principles of SR 
into their everyday activities and hobbies by trying to 
undertake tasks requiring fine dexterity with their eyes 
closed, attending to the feel of the surface or object and 
using vision only intermittently. These patients also 
reported greater benefit from the intervention and con-
tinued to practise SR after the initial 6 weeks. However, 
it is also evident from the diary comments that for 
some the SR programme was too easy or boring and 
those patients lost motivation, some withdrawing from 
the intervention or the trial altogether.
Finally, the mean age of the trial participants was 
relatively high (>70 years). Although cognitive func-
tion declines with age, the ability to learn new skills 
(neural plasticity) remains (Cai et al., 2014; Leung 
et al., 2015). The way in which the exercises were 
enacted may have varied depending more on the per-
son’s cognitive ability, motivation and activity levels 
rather than age per se.
This trial posed several challenges. First, to iden-
tify patients with sensory impairment after carpal 
tunnel compression. Patients are not routinely 
assessed after surgery and therefore chronic sensory 
impairment is rarely documented in primary care 
records. However, the patient self-report did prove to 
be highly sensitive in identifying those who have sen-
sory deficits on objective testing (88%). The second 
challenge was the high attrition observed in the 
intervention group. Even for those who did remain in 
the trial, adherence to the intervention was subopti-
mal in 42% of patients allocated to the intervention. 
Reasons for withdrawal and non-adherence appear 
to be a combination of patient and intervention-
related factors. First, the intervention may have not 
been a good fit to the patients’ specific problems thus 
resulting in early non-adherence. Furthermore, even 
among those who intended to comply or who were 
partial compliers, many forgot or were unable to find 
the time in their daily routine to do the exercises. SR 
requires patients to relearn the way they attend to 
their touch sense. Compensatory behaviours such as 
relying on vision or using the other hand due to poor 
sensibility may need to be ‘unlearned’. Factors such 
as patient self-efficacy, motivation and opportunity to 
engage with the exercises may play an important role 
in whether SR is seen as a worthwhile behaviour to 
learn. Behaviour change taxonomy (Michie et al., 
2015), which has been applied in the context of public 
health interventions such as promoting increased 
physical activity, may offer a useful framework for 
future sensory relearning intervention development.
Strengths and limitations
Strengths of this trial include the use of objective 
standardized measures of hand sensibility, and an 
adequately powered sample size. The intervention 
used in this trial, including the materials and instruc-
tions, were standardized and therefore replicable. In 
order to maximize treatment fidelity, the same per-
son (CI) delivered the intervention to all patients.
There are also several limitations. Although loss to 
follow-up was only 10% for the whole cohort, attrition 
was much greater in the intervention group and may 
have biased the outcome. While assessor blinding 
was used, there were several instances of unblinding. 
The most likely bias arising from unblinded assess-
ment is that it favours the experimental intervention 
and leads to an overestimate of effect (Poolman et al., 
2007), however this was not observed in our trial. 
Finally, adherence with SR was patient reported and 
could not be independently verified.
Conclusions and implications
Identification of chronic sensory impairment after 
carpal tunnel decompression and targeting of thera-
pies to improve functional sensibility and hand func-
tion in this population may require alternative 
strategies. At present there is no evidence to support 
the use of unsupervised SR as an intervention for 
patients with tactile sensory and functional deficits 
after carpal tunnel decompression. Further research 
is needed on how SR programmes can be designed 
that are practicable, affordable and sufficiently chal-
lenging to maximize adherence. This may require 
more individually tailored exercises to address 
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specific sensory deficits, more therapist supervised 
sessions or at least frequent monitoring of patient 
progress to grade and progress the complexity of the 
therapy programme. There is also the potential to use 
multimedia, including online video instructions dem-
onstrating the exercises or development of smart-
phone applications to monitor SR practice, enhance 
motivation and provide positive reinforcement.
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